Skip to main content
. Author manuscript; available in PMC: 2015 Jun 5.
Published in final edited form as: Mol Cancer Ther. 2008 May;7(5):1275–1284. doi: 10.1158/1535-7163.MCT-07-2043

Figure 4.

Figure 4

Representive histology of the effects of vehicle (A), tazarotene (B), ATRA (C), RARα agonist (D), RXR agonist (E), or RAR antagonist (F) on UV-irradiated Ptch1 +/− dorsal back skin at age 9 months. Microscopic BCC lesions were stained blue for β-galactosidase activity (arrows).